v3.25.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Disaggregated Amounts of Research and Development Expenses In addition to the significant expense categories included within consolidated net loss presented in the condensed consolidated statements of operations and comprehensive loss, see below for disaggregated amounts that comprise research and development expenses (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

 

 

 

 

 

 

 

 

 

 

 

Direct research and development expenses
  by program:

 

 

 

 

 

 

 

 

 

 

 

 

IK-930

 

$

313

 

 

$

3,846

 

 

$

712

 

 

$

6,304

 

IK-595

 

 

3,123

 

 

 

2,318

 

 

 

5,574

 

 

 

3,982

 

IK-175

 

 

33

 

 

 

86

 

 

 

41

 

 

 

498

 

Discovery and other programs

 

 

64

 

 

 

802

 

 

 

85

 

 

 

759

 

Unallocated expense:

 

 

 

 

 

 

 

 

 

 

 

 

Personnel related (including stock-based
  compensation)

 

 

313

 

 

 

2,150

 

 

 

948

 

 

 

5,722

 

Other research and development cost

 

 

179

 

 

 

630

 

 

 

380

 

 

 

2,212

 

Total research and development expenses

 

$

4,025

 

 

$

9,832

 

 

$

7,740

 

 

$

19,477